1-7 of 7
Cristina Ivan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models

Available to Purchase
Katelyn F. Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar, Santosh K. Dasari, Nghi Nguyen, Reid T. Powell, Mary Sobieski, Cristina Ivan, Mark Kim, Sujanitha Umamaheswaran, Deanna Glassman, Yunfei Wen, Paola Amero, Clifford Stephan, Robert L. Coleman, Yosef Landesman, Shannon N. Westin, Prahlad T. Ram, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12): 2352–2361.
https://doi.org/10.1158/1535-7163.MCT-21-0370
Published: 03 December 2021
View article titled, Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models
Open the PDF for Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models in another window
Includes: Supplementary data
Journal Articles

Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4

Free
Alejandro Villar-Prados, Sherry Y. Wu, Karem A. Court, Shaolin Ma, Christopher LaFargue, Mamur A. Chowdhury, Margaret I. Engelhardt, Cristina Ivan, Prahlad T. Ram, Ying Wang, Keith Baggerly, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Shyh-Ming Yang, David J. Maloney, Makoto Yoshioka, Jeffrey W. Strovel, Jason Roszik, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (2): 421–436.
https://doi.org/10.1158/1535-7163.MCT-18-0365
Published: 04 February 2019
View article titled, Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4
Open the PDF for Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4 in another window
Includes: Supplementary data
Journal Articles

PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer

Free
Takeshi Hisamatsu, Michael McGuire, Sherry Y. Wu, Rajesha Rupaimoole, Sunila Pradeep, Emine Bayraktar, Kyunghee Noh, Wei Hu, Jean M. Hansen, Yasmin Lyons, Kshipra M. Gharpure, Archana S. Nagaraja, Lingegowda S. Mangala, Takashi Mitamura, Cristian Rodriguez-Aguayo, Young Gyu Eun, Johnathon Rose, Geoffrey Bartholomeusz, Cristina Ivan, Ju-Seog Lee, Koji Matsuo, Michael Frumovitz, Kwong K. Wong, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (1): 162–172.
https://doi.org/10.1158/1535-7163.MCT-17-1050
Published: 02 January 2019
View article titled, PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer
Open the PDF for PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer

Free
Yan Huang, Wei Hu, Jie Huang, Fangrong Shen, Yunjie Sun, Cristina Ivan, Sunila Pradeep, Robert Dood, Monika Haemmerle, Dahai Jiang, Lingegowda S. Mangala, Kyunghee Noh, Jean M. Hansen, Heather J. Dalton, Rebecca A. Previs, Archana S. Nagaraja, Michael McGuire, Nicholas B. Jennings, Russell Broaddus, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (2): 464–473.
https://doi.org/10.1158/1535-7163.MCT-17-0006
Published: 01 February 2018
View article titled, Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer
Open the PDF for Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting c-MYC in Platinum-Resistant Ovarian Cancer

Free
Jeyshka M. Reyes-González, Guillermo N. Armaiz-Peña, Lingegowda S. Mangala, Fatma Valiyeva, Cristina Ivan, Sunila Pradeep, Ileabett M. Echevarría-Vargas, Adrian Rivera-Reyes, Anil K. Sood, Pablo E. Vivas-Mejía
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (10): 2260–2269.
https://doi.org/10.1158/1535-7163.MCT-14-0801
Published: 05 October 2015
View article titled, Targeting c-MYC in Platinum-Resistant Ovarian Cancer
Open the PDF for Targeting c-MYC in Platinum-Resistant Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer

Free
Duangmani Thanapprapasr, Rebecca A. Previs, Wei Hu, Cristina Ivan, Guillermo N. Armaiz-Pena, Piotr L. Dorniak, Jean M. Hansen, Rajesha Rupaimoole, Jie Huang, Heather J. Dalton, Rouba Ali-Fehmi, Robert L. Coleman, Anil K. Sood
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (6): 1466–1475.
https://doi.org/10.1158/1535-7163.MCT-14-1077
Published: 04 June 2015
View article titled, PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer
Open the PDF for PTEN Expression as a Predictor of Response to Focal Adhesion Kinase Inhibition in Uterine Cancer in another window
Includes: Supplementary data
Journal Articles

Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin–Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma

Free
Vianey Gonzalez-Villasana, Cristian Rodriguez-Aguayo, Thiruvengadam Arumugam, Zobeida Cruz-Monserrate, Enrique Fuentes-Mattei, Defeng Deng, Rosa F. Hwang, Huamin Wang, Cristina Ivan, Raul Joshua Garza, Evan Cohen, Hui Gao, Guillermo N. Armaiz-Pena, Paloma del C. Monroig-Bosque, Bincy Philip, Mohammed H. Rashed, Burcu Aslan, Mumin Alper Erdogan, Yolanda Gutierrez-Puente, Bulent Ozpolat, James M. Reuben, Anil K. Sood, Craig Logsdon, Gabriel Lopez-Berestein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (11): 2583–2594.
https://doi.org/10.1158/1535-7163.MCT-14-0028
Published: 03 November 2014
View article titled, Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin–Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma
Open the PDF for Bisphosphonates Inhibit Stellate Cell Activity and Enhance Antitumor Effects of Nanoparticle Albumin–Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data